Crystal Lantrip, Yvette Z Szabo, F Andrew Kozel, Paul Holtzheimer
{"title":"Neuromodulation as an Augmenting Strategy for Behavioral Therapies for Anxiety and PTSD: a Narrative Review.","authors":"Crystal Lantrip, Yvette Z Szabo, F Andrew Kozel, Paul Holtzheimer","doi":"","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose of review: </strong>Post-traumatic stress disorder (PTSD) is a prevalent problem. Despite current treatments, symptoms may persist, and neuromodulation therapies show great potential. A growing body of research suggests that transcranial magnetic stimulation (TMS) is effective as a standalone treatment for PTSD, with recent research demonstrating promising use when combined synergistically with behavioral treatments. In this review, we survey this literature including data suggesting mechanisms involved in anxiety and PTSD that may be targeted by neurostimulation.</p><p><strong>Recent findings: </strong>Evidence suggests the mechanism of action for TMS that contributes to behavioral change may be enhanced neural plasticity via increased functionality of prefrontal and subcortical/limbic structures and associated networks. Some research has demonstrated a behavioral change in PTSD and anxiety due to enhanced extinction learning or improved ability to think flexibly and reduce ruminative tendencies. Growing evidence suggests TMS may be best used as a therapeutic adjunct, at least acutely, for extinction-based exposure therapies in patients by accelerating therapy response.</p><p><strong>Summary: </strong>While TMS has shown promise as a standalone intervention, augmentation with psychotherapy is one avenue of interest. Non-responders to current EBPs might particularly benefit from this sort of targeted approach, and it may shorten treatment length, which would help the successful completion of a course of therapy.</p>","PeriodicalId":11088,"journal":{"name":"Current Treatment Options in Psychiatry","volume":"9 ","pages":"406-418"},"PeriodicalIF":0.0000,"publicationDate":"2022-09-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9881183/pdf/nihms-1859576.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Treatment Options in Psychiatry","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"Psychology","Score":null,"Total":0}
引用次数: 0
Abstract
Purpose of review: Post-traumatic stress disorder (PTSD) is a prevalent problem. Despite current treatments, symptoms may persist, and neuromodulation therapies show great potential. A growing body of research suggests that transcranial magnetic stimulation (TMS) is effective as a standalone treatment for PTSD, with recent research demonstrating promising use when combined synergistically with behavioral treatments. In this review, we survey this literature including data suggesting mechanisms involved in anxiety and PTSD that may be targeted by neurostimulation.
Recent findings: Evidence suggests the mechanism of action for TMS that contributes to behavioral change may be enhanced neural plasticity via increased functionality of prefrontal and subcortical/limbic structures and associated networks. Some research has demonstrated a behavioral change in PTSD and anxiety due to enhanced extinction learning or improved ability to think flexibly and reduce ruminative tendencies. Growing evidence suggests TMS may be best used as a therapeutic adjunct, at least acutely, for extinction-based exposure therapies in patients by accelerating therapy response.
Summary: While TMS has shown promise as a standalone intervention, augmentation with psychotherapy is one avenue of interest. Non-responders to current EBPs might particularly benefit from this sort of targeted approach, and it may shorten treatment length, which would help the successful completion of a course of therapy.
期刊介绍:
This journal focuses on the latest advances in the multifaceted treatment of psychiatric disorders. Designed for physicians and other mental health professionals, Current Treatment Options in Psychiatry offers expert reviews on the management of a range of mental health conditions, includingSchizophrenia and other psychotic disordersSubstance use disordersAnxiety, obsessive-compulsive, and related disordersMood disordersEating and other impulse control disordersPersonality disordersArticles cover a range of established and emerging treatment options across the lifespan, and their innovative, hands-on format makes them ideal for informing treatment decisions at the point of care.We accomplish this by appointing leaders in the field to serve as Section Editors in key areas. Section Editors, in turn, select the most pressing topics as well as experts to present the latest research, assess the efficacy of available treatment options, and discuss special considerations.Additionally, an international Editorial Board—representing a range of disciplines within psychiatry and psychology—ensures that the journal content includes current, emerging research and suggests articles of special interest to their country or region.